Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health is seeking applications for the Centers of Biomedical Research Excellence: Development Phase (COBRE-D) grant program to build biomedical research capacity in states with historically low levels of agency funding. Eligible institutions must use the funding to increase research capacity in a strategic scientific area where they currently have limited infrastructure or expertise. Supported activities include recruiting and mentoring early-career investigators, providing supplemental start-up packages for new hires, establishing research facilities, and enhancing research administration support services. Eligible applicants are restricted to doctoral-degree-granting institutions or independent biomedical research institutes located in IDeA-eligible states and jurisdictions. Applications are being accepted through May 26, 2029, and inquiries can be directed to NIGMS_COBRE_D@mail.nih.gov.
Eligible Applicants
Eligibility is restricted to institutions that meet the following criteria:Are located in an IDeA-eligible state, commonwealth, or jurisdiction, which are Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Puerto Rico, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, and Wyoming; andAward doctoral degrees in the health-related sciences or are independent biomedical research institutes/medical centers with ongoing biomedical research programs funded by the NIH or other federal agencies.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Note:Unfunded foreign components are allowed with prior approval.An unfunded foreign component would be a collaboration with investigators at a foreign site anticipated to result in co-authorship, when no IDeA funds are transferred via subcontract to an institution in a foreign country. Please also see NOT-OD-26-084.Foreign PIs or organizations may use center resources as a fee-for-service.In such cases, resulting publications cannot cite or acknowledge NIH grant support.
Grant Documents
No documents available for this grant.